How big is the Chronic Kidney Disease Drugs Market ?
Global Chronic Kidney Disease Drugs Market was valued at US$ 10,923.29 million in 2021 and is estimated to reach US$ 19,427.41 million by 2031.
Who are the key players in Global Chronic Kidney Disease Drugs Market ?
Major players are AstraZeneca Plc, Sanofi S.A, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, AstraZeneca Plc, Kissei Pharmaceutical Co, AbbVie Inc, GlaxoSmithKline Plc, Amgen Inc, Akebia Therapeutics and Pfizer Inc.